NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Effects of sterilizing gamma irradiation on bloodspot newborn screening tests and whole blood cyclosporine and tacrolimus measurements.

Author(s): Stickle DF, McKenzie DA, Landmark JD, Pirruccello SJ, Post GR, Iwen PC, Thompson RB, Hinrichs SH

Publication: Am J Clin Pathol, 2003, Vol. 119, Page 292-7

PubMed ID: 12580001 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine the effects of gamma irradiation, such as that which occurs during mailing, on cyclosporine and tacrolimus concentrations in blood and on newborn blood screening results.

Conclusion of Paper

Tacrolimus and cyclosporine concentrations in blood were not significantly affected by gamma irradiation. Phenylalanine, biotinidase, galactose- 1-phosphate, uridyltransferase, thyroxine (T4) and thyrotropin levels declined after irradiation. However, only the effects on phenylalanine were clinically significant. While the hemoglobin genetic variant was properly identified in all specimens, the hemoglobin fraction distributions were altered after gamma irradiation, which would flag specimens in a clinical setting for additional testing.

Studies

  1. Study Purpose

    The purpose of this study was to determine the effects of a 100 h exposure to 18 kGy gamma irradiation, such as what would occur during mailing, on cyclosporine and tacrolimus concentrations in blood specimens. Non-irradiated specimens were put in plastic bags and placed next to the machine for the duration of irradiation. No specimens were actually mailed. All specimens were tested less than 48 h after irradiation.

    Summary of Findings:

    Tacrolimus concentrations showed an insignificant decline of 10% in gamma irradiated blood specimens. The authors hypothesize the decline was possibly due to the small specimen number (5) and/or the high interassay variance (11%). Cyclosporine concentrations in blood were not affected by gamma irradiation.

    Biospecimens
    Preservative Types
    • None (Fresh)
    Diagnoses:
    • Not specified
    Platform:
    AnalyteTechnology Platform
    Small molecule Immunoassay
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Storage Storage conditions With 18 kGy gamma irradiation
    Without irradiation
    Storage Between site transportation method Mailed
    Not transported
  2. Study Purpose

    The purpose of this study was to determine the effects of 100 h exposure to 18 kGy gamma irradiation, such as what would occur during mailing, on newborn blood screening results in dried blood spots. Non-irradiated specimens were put in plastic bags and placed next to the machine for the duration of irradiation. No specimens were actually mailed. All specimens were tested less than 48 h after irradiation. Blood spots for phenylalanine analysis were prepared using supplemented adult blood, and blood spots for thyrotropin were prepared from adult serum. All other blood spots were from routine newborn blood testing.

    Summary of Findings:

    A 9% decline in hyperphenylalaninemia was measured in the irradiated specimens (p=0.03). Gamma irradiation also caused levels of biotinidase and galactose-1-phosphate uridyltransferase to decrease by 40% and 50%, respectively (both, p<0.001), but even after irradiation, all specimens maintained levels necessary for proper clinical classification, so irradiation was clinically insignificant. T4 and thyrotropin levels also declined after irradiation by 27% and 32%, respectively (both, p<0.005), but the authors report decreases of this magnitude are unlikely to affect clinical diagnosis. While the hemoglobin genetic variant was properly identified in all specimens, the hemoglobin fast fraction was elevated, and the A and S fractions were decreased in irradiated specimens compared to non-irradiated specimens, which, the authors report, would flag the specimens for repeat testing in a clinical setting.

    Biospecimens
    Preservative Types
    • Other Preservative
    Diagnoses:
    • Not specified
    • Other diagnoses
    Platform:
    AnalyteTechnology Platform
    Protein Clinical chemistry/auto analyzer
    Protein Colorimetric assay
    Protein HPLC
    Peptide Immunoassay
    Small molecule Fluorometry
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Storage Between site transportation method Mailed
    Not transported
    Storage Storage conditions With 18 kGy gamma irradiation
    Without irradiation
    Preaquisition Patient genotype Hemoglobin F and A
    Heterozygous for beta chain hemoglobin variants

You Recently Viewed  

News and Announcements

  • Most Downloaded SOPs in 2024

  • New Articles on the GTEx Project are Now FREELY Available!

  • Just Published!

  • More...